Key facts
- MassBio is a other based in Cambridge, Massachusetts with 14 tracked portfolio companies.
- Notable positions include Dxcover, InGel Therapeutics, Augment Biologics, D2B3, HarborSite.
About MassBio
Founded in 1985, MassBio is an accelerator based in Cambridge, Massachusetts. The firm runs programs and focuses on life sciences sectors.
Free account
See the whole book
- ·The book's top 25 — of 14 recorded positions
- ·Watchlist + alerts for MassBio's activity
Create free account
No card required
Portfolio, priced
14 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Dxcover | — | $37.8M | — | |
| InGel Therapeutics | — | $17.0M | — | |
| Augment Biologics | — | — | — | |
| D2B3 | — | — | — | |
| HarborSite | — | — | — | |
| Laurel Biotherapeutics | — | — | — | |
| Meta-Flux | — | — | — | |
| Modulate Bio | — | — | — | |
| Orion Therapeutics | — | — | — | |
| PathCision Medicine | — | — | — | |
| Signet Therapeutics | — | — | — | |
| Cloverleaf Bio | — | — | — | |
| TMAB Therapeutics | — | — | — | |
| HDAX Therapeutics | — | — | — |
Frequently asked
- What companies does MassBio invest in?
- MassBio has 14 recorded portfolio companies, including Dxcover, InGel Therapeutics, Augment Biologics, D2B3.